KBC Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,434
Closed -$40K 1788
2025
Q1
$40K Hold
4,434
﹤0.01% 1827
2024
Q4
$58K Buy
4,434
+2,197
+98% +$29.3K ﹤0.01% 1787
2024
Q3
$35K Hold
2,237
﹤0.01% 1814
2024
Q2
$30K Hold
2,237
﹤0.01% 1818
2024
Q1
$62K Hold
2,237
﹤0.01% 1419
2023
Q4
$43K Sell
2,237
-373
-14% -$6.75K ﹤0.01% 1633
2023
Q3
$42K Sell
2,610
-2,974
-53% -$52.8K ﹤0.01% 1588
2023
Q2
$106K Sell
5,584
-1,153
-17% -$20.6K ﹤0.01% 1164
2023
Q1
$98K Hold
6,737
﹤0.01% 1205
2022
Q4
$132K Hold
6,737
﹤0.01% 1105
2022
Q3
$162K Hold
6,737
﹤0.01% 1029
2022
Q2
$212K Buy
+6,737
New +$244K ﹤0.01% 968
2021
Q3
Sell
-4,984
Closed -$210K 1322
2021
Q2
$210K Buy
+4,984
New +$194K ﹤0.01% 1164
2019
Q1
Sell
-140,764
Closed -$891K 1428
2018
Q4
$891K Sell
140,764
-174,915
-55% -$1.82M 0.01% 779
2018
Q3
$5.21M Buy
315,679
+131,337
+71% +$2.23M 0.04% 424
2018
Q2
$3.08M Sell
184,342
-20,551
-10% -$333K 0.03% 507
2018
Q1
$3.19M Sell
204,893
-58,662
-22% -$1.05M 0.03% 474
2017
Q4
$4.98M Buy
263,555
+185,360
+237% +$4.11M 0.04% 407
2017
Q3
$2.28M Buy
+78,195
New +$2.31M 0.02% 581

Other funds holding ACH

KBC Group's ACH Position: Q2 2025 in Review

KBC Group sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 4,434 shares — an estimated $40K sold.

KBC Group first reported a position in ACH in Q3 2017 and held it in 19 quarters. The position peaked at $5.21M in Q3 2018. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • KBC Group reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • KBC Group sold 4,434 Accendra Health shares in Q2 2025, an estimated $40K.
  • KBC Group first reported a position in Accendra Health in Q3 2017 and held it in 19 quarters.
  • KBC Group's Accendra Health position peaked at $5.21M in Q3 2018.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.